Habib J. Dable is CEO & President at ACCELERON PHARMA INC (XLRN). They have made 8 open-market trades across 1 company since 2018, most recently 2025-07-17.
CIK 0001690773
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL | 2021-07-01 | 2021-07-02 | $126.83 | $22.4M | -8.2% | -0.7% | +37.0% |
| XLRN | SELL | 2021-01-05 | 2021-01-06 | $121.33 | $609K | +7.6% | +4.0% | +12.6% |
| XLRN | SELL | 2020-07-01 | 2020-07-06 | $96.55 | $8.9M | -4.9% | +3.6% | +7.0% |
| XLRN | SELL | 2020-01-03 | 2020-01-03 | $51.24 | $377K | +8.0% | +85.0% | +66.2% |
| XLRN | SELL | 2019-09-10 | 2019-09-10 | $45.21 | $493K | -5.7% | -16.1% | +9.2% |
| XLRN | SELL | 2019-04-09 | 2019-04-11 | $44.60 | $654K | -7.1% | -6.9% | -5.0% |
| XLRN | SELL | 2019-01-03 | 2019-01-04 | $43.43 | $169K | +2.4% | +3.4% | +10.7% |
| XLRN | SELL | 2018-12-04 | 2018-12-06 | $52.95 | $1.3M | -11.5% | -9.3% | -11.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.